Volume 14, Number 4—April 2008
Single Nucleotide Polymorphism Typing of Bacillus anthracis from Sverdlovsk Tissue
A small number of conserved canonical single nucleotide polymorphisms (canSNP) that define major phylogenetic branches for Bacillus anthracis were used to place a Sverdlovsk patient’s B. anthracis genotype into 1 of 12 subgroups. Reconstruction of the pagA gene also showed a unique SNP that defines a new lineage for B. anthracis.
The 1979 accidental release of Bacillus anthracis spores in the northeastern quadrant of Sverdlovsk (today’s Ekaterinburg) in the former Soviet Union resulted in a relatively large-scale incident of inhalation anthrax (1). Histologic examinations of formalin-fixed, paraffin-embedded tissue samples from patients affected by this incident showed pathologic changes (2). Paraffin-embedded material from 11 of these patients was also subjected to molecular DNA analysis to demonstrate the presence of B. anthracis plasmid markers (3). These tissue samples appeared to contain 3–4 allelic variants of B. anthracis, based on a single variable-number tandem repeat (VNTR) marker (vrrA), which suggests that the material contained multiple strains of this species (4).
An early global comparison of the entire pagA gene sequence from 26 diverse B. anthracis isolates and a single nucleotide polymorphism (SNP)–rich region (307 bp) of the samples from Sverdlovsk found 7 SNPs in this gene (5). Two of these SNPs were unique to 3 of the Sverdlovsk samples. However, the distribution of the remaining 5 SNPs separated the 26 diverse isolates and the remaining Sverdlovsk samples into clusters that were consistent with diversity groups previously described by amplified fragment–length polymorphism (AFLP) analysis of a larger subset of isolates (6). The AFLP analysis had separated a collection of 78 isolates into 5 diversity groups. Although only 307 bp of the Sverdlovsk tissue samples were sequenced, a single SNP (pagA SNP 3602) placed 7 of 10 Sverdlovsk tissue samples into a large diversity group called western North America (WNA) (5).
Recent comparisons among 5 B. anthracis whole genome sequences uncovered ≈3,000 SNPs, and the rigorous examination of ≈1,000 of these SNPs across 27 diverse isolates demonstrated an extremely conserved clonal population structure for this species (7,8). These results led to a genotyping method that uses a small number of canonical SNPs (canSNPs) to replace the analysis of ≈1,000 SNPs and still precisely defines key positions and branch points within the B. anthracis tree (9). This canSNP model was recently tested against a large, diverse B. anthracis collection of 1,033 isolates (10). When all 1,033 isolates were evaluated against a panel of 13 canSNPs, the results demonstrated that each B. anthracis isolate had 1 of only 12 different canSNP profiles. These analyses supported the notion that a single canSNP can be used to represent an entire genome when the genome being examined is as conserved as that of B. anthracis (7–9). This strategy was applied to the analysis of a Sverdlovsk sample that appears to represent a single diversity group previously recognized as WNA from pagA sequence analysis.
DNA was extracted by using QiaAmp DNA Mini Kits (QIAGEN, Valencia, CA, USA), following protocols recommended for formalin-fixed tissue samples. A Genomeplex Whole Genome Amplication Kit (Sigma, St. Louis, MO, USA) was used to preamplify the extracted DNA sample. Short DNA fragments were amplified from these DNA samples by using the following primer sets: canSNP.A.Br.008 F: 5′-GCCAAGATATTCGTGACATT-3′; canSNP.A.Br.008 R: 5′-TTTGGACCAGGTTTCTGTATTT-3′; canSNP A.Br.009 F: 5′-TGCGGAATATCGTTAAGTAAT-3′; canSNP A.Br.009R: 5′-TGGACGTGAATTAGGAAAAGT-3′ (for traditional PCR and sequencing); canSNP A.Br.008 F: 5′-TCTAAGAAAGATTCGCAACTACGCTATAC-3′; canSNP A.Br.008 R: 5′-TGCATTCGCAACTACGCTATACGTTTTAGATG-3′; canSNP A.Br.009 F: 5′-TGCCGGGGTTTCTACTGTGTATGTTGT-3′; canSNP A.Br.009 R: 5′-TGGGTTAGGTATATTAACTGCGGATGATGC-3′ (for mass spectrometry base composition analysis); pagA 981 F: 5′-AATGAGGATCAATCCACACAG-3′; and pagA 981 R: 5′-ATTTAAACCCATTGTTTCAGC-3′. Traditional PCR amplification schemes and DNA sequencing techniques were used for sequencing with an ABI 3100 DNA Analyzer (Applied Biosystems, Foster City, CA, USA). The mass spectrometry resequencing technique is described in detail elsewhere (11). Primers for real-time PCR were as follows: PagSNP.981F 5′-CACAGAATACTGATAGTCAAACGAGAACA-3′; PagSNP.981R 5′-GCACTTCTGCATTTCCATGTACTT-3′; probe 1: PagSNP.981T VIC 5′-ACAAGTAGGACtCATAC-3′; and probe 2: PagSNP.981A 6FAM 5′-CAAGTAGGACaCATACT-3′.
The Figure illustrates the relative positions of 3 canSNPs along the branches of the canSNP-derived phylogenetic tree for the 1,033 B. anthracis isolates (10). The focus of this diagram is the WNA lineage (A.Br.WNA), which forms a branch and a node part way along this branch. CanSNP typing both by traditional sequencing and by the mass spectrometry resequencing technique of the 2 positions (10) that define the WNA lineage (A.Br.WNA) and a branch point designated A.Br.008/009 (canSNPs in red; A.Br.008, and A.Br.009, respectively; Figure) confirms that the Sverdlovsk sample 7.RA93.15.15 (Table) is related to the WNA lineage. However, the canSNP genotype of the Sverdlovsk sample indicates that although it may share a common ancestor with the WNA lineage, it is a member of the A Branch.008/009 subgroup that comprises isolates (n = 154) that were recovered primarily from Europe and portions of Asia (10). The close relationship between the WNA sublineage and this major European/Asian subgroup is consistent with the hypothesis that B. anthracis was introduced into the North American continent by European settlers, possibly from France or Spain (10,12).
The early vrrA and pagA gene studies on Sverdlovsk tissue samples suggested that they contained multiple strains of B. anthracis because several vrrA alleles and pagA genotypes were noted. However, a dominant vrrA allele (4 repeats), as measured by both the quantity and the quality of the PCR products, was found in 9 of 13 samples from the tissue specimens (3). In some samples, it was the only allele present. Similarly, the pagA diversity group V signal (pagA SNP 5 at bp 3602 or bp 1791 from the ATG start) for the WNA subgroup appeared in 7 of 10 samples of the Sverdlovsk tissues (5). Sverdlovsk sample 7.RA93.15.15 contained these dominant allele signals, which suggests that these signals represent a single, specific strain of this pathogen.
In addition to the analysis of the canSNPs that define the A.Br.008/009 sublineage, large portions of the pagA gene sequence were reconstructed from sample 7.RA93.15.15 by using 40 overlapping PCR fragments without whole genome amplification. The reconstruction of this gene as well as other loci was not always feasible for many of the remaining Sverdlovsk samples because of limited DNA. Sequence analysis of these PCR products showed a new A–T synonymous transversion mutation (Table) at pagA position bp 981, where the start ATG = bp 1, 2, 3, or position 2784 by using the coordinates described by Price et al. (5). This SNP was not found in any of the original 27 diverse B. anthracis isolates (5) or in a recent pagA gene sequencing analysis of 124 archival B. anthracis samples from the Centers for Disease Control and Prevention (13). The status of the new pagA 981 site was also analyzed in a panel of isolates containing 89 diverse multiple-locus, variable-number, tandem-repeat analysis genotypes and an additional 154 A.Br.008/009 subgroup (Eurasian) isolates by using a custom made real-time PCR assay: TaqMan Minor Groove Binding probes and primers for SNPs (Applied Biosystems) (14). These analyses indicate that the pagA 981 A–T transversion represents a rare SNP allele found in only 3 Eurasian isolates and the Sverdlovsk 7.RA93.15.15 sample. (The Table shows isolates with the rare allele and a sampling of the additional Eurasian isolates.) This real-time PCR protocol is applicable to low copy–number templates and, somewhat, to mixed sample analyses. We applied it to DNA extracted from the remaining 12 Sverdlovsk tissue samples (3). Seven of these templates supported extensive amplification and detected only the “T” allele at this SNP locus (Table) with no evidence for the alternate “A” allele.
The tissue samples with pagA 981 SNP real-time PCR amplification were the same as samples that displayed the single vrrA 4-repeat signal (group V), except for 1 sample (40.RA93.40.5, spleen) that contained a mixture of the vrrA 2, 4, and 5 repeats. With this exception, a mixed signal could not be predicted from the previous results (3,5). Why a mixed signal was not seen in the latter sample is not clear, although multiple explanations exist, including the loss or curing of plasmid in certain genomes during mass culture. The remaining samples with multiple vrrA alleles did not produce amplicons in the pagA 981 real time assay.
CanSNP typing provides insight into a dominant strain involved in the 1979 Sverdlovsk anthrax outbreak and identifies it as part of a large cluster of isolates (A.Br.008/009) that are found in Europe and Asia. Our findings are consistent with claims that the weaponized strain released in Sverdlovsk (Anthrax 836) was originally isolated from a rodent in the city of Kirov, Soviet Union, in the mid-1950s (15). These findings are not in conflict with reports that grouped the Sverdlovsk strain with the WNA sublineage because this recently defined Eurasian cluster shares a common ancestor with the WNA isolates (7,10). Reconstruction of the pagA gene sequence from this Sverdlovsk sample uncovered a new SNP at position 981, which appears to be specific for a small subset of Eurasian isolates. This SNP creates a branch emanating from the A.Br.008/009 node and currently contains only 3 isolates plus the prominent Sverdlovsk genotype. The extremely conserved nature of the B. anthracis genome (7), coupled with analysis of more than 230 close and diverse isolates, suggests that the pagA 981 transversion represents a new canSNP that can rapidly identify the closest relatives of this distinct Sverdlovsk lineage.
Dr Okinaka is a research scientist at Northern Arizona University. His interests have focused on the molecular analysis of mutations in humans and microbial pathogens, with particular emphasis on the sequencing analysis of B. anthracis and its plasmids.
Funding was provided by the Intelligence Technology Innovation Center to Los Alamos National Laboratory and IBS Biosciences and by Sponsor Award NBCH2070001 to Northern Arizona University by the Department of Homeland Security Science and Technology Directorate.
- Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202–8.
- Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291–4.
- Jackson PJ, Hugh-Jones ME, Adair DM, Green G, Hill KK, Kuske CR, PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc Natl Acad Sci U S A. 1998;95:1224–9.
- Jackson PJ, Walthers EA, Kalif AS, Richmond KL, Adair DM, Hill KK, Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates. Appl Environ Microbiol. 1997;63:1400–5.
- Price LB, Hugh-Jones M, Jackson PJ, Keim P. Genetic diversity in the protective antigen gene of Bacillus anthracis. J Bacteriol. 1999;181:2358–62.
- Keim P, Kalif A, Schupp J, Hill K, Travis SE, Richmond K, Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol. 1997;179:818–24.
- Pearson T, Busch JD, Ravel J, Read TD, Rhoton SD, U’Ren JM, Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci U S A. 2004;101:13536–41.
- Worobey M. Anthrax and the art of war (against ascertainment bias). Heredity. 2005;94:459–60.
- Keim P, Van Ert MN, Pearson T, Vogler AJ, Huynh LY, Wagner DM. Anthrax molecular epidemiology and forensics: using the appropriate marker for different evolutionary scales. Infect Genet Evol. 2004;4:205–13.
- Van Ert MN, Easterday WR, Huynh LY, Okinaka RT, Hugh-Jones ME, Ravel J, Global genetic population structure of Bacillus anthracis.. PLoS One. 2007;2:e461.
- Van Ert MN, Hofstadler SA, Jiang Y, Busch JD, Wagner DM, Drader JJ, Mass spectrometry provides accurate characterization of two genetic markers in Bacillus anthracis. Biotechniques. 2004;37:642–51.
- Hanson RP. The earliest account of anthrax in man and animals in North America. J Am Vet Med Assoc. 1959;135:463–5.
- Sue D, Marston CK, Hoffmaster AR, Wilkins PP. Genetic diversity in a historical collection of Bacillus anthracis (1954–1988). J Clin Microbiol. 2007;45:1777–82.
- Van Ert MN, Easterday WR, Simonson TS, U’Ren JM, Pearson T, Kenefic LJ, Strain-specific single-nucleotide polymorphism assays for the Bacillus anthracis Ames strain. J Clin Microbiol. 2007;45:47–53.
- Alibeck K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world. New York: Dell Publishing; 1999.
- Figure. Schematic single nucleotide polymorphism (SNP) tree for Bacillus anthracis. This tree illustrates the relative positions of several sequenced strains of B. anthracis that form the specific sublineages in the A...
- Table. Canonical single nucleotide polymorphism (canSNP) typing and a new pagA SNP from Sverdlovsk 7.RA93.15.15 (spleen) View Actual Table
Suggested citation for this article: Okinaka RT, Hill KK, Lowery KS, Van Ert M, Pearson T, Schupp, et al. Single nucleotide polymorphism typing of Bacillus anthracis from Sverdlovsk tissue. Emerg Infect Dis [serial on the Internet]. 2008 Apr [date cited]. Available from http://wwwnc.cdc.gov/eid/article/14/4/07-0984
Please use the form below to submit correspondence to the authors or contact them at the following address:
Paul Keim, Department of Biological Sciences, Northern Arizona University, Flagstaff, AZ 86011-5640, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 13, 2010
- Page last updated: July 13, 2010
- Page last reviewed: July 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)